EA202190856A1 - METHODS OF TREATMENT - Google Patents

METHODS OF TREATMENT

Info

Publication number
EA202190856A1
EA202190856A1 EA202190856A EA202190856A EA202190856A1 EA 202190856 A1 EA202190856 A1 EA 202190856A1 EA 202190856 A EA202190856 A EA 202190856A EA 202190856 A EA202190856 A EA 202190856A EA 202190856 A1 EA202190856 A1 EA 202190856A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
treatment
cancer
compositions
tumor antigens
Prior art date
Application number
EA202190856A
Other languages
Russian (ru)
Inventor
Джессика Бейкер Флехтнер
Мари Лосски-Элайас
Памела М. Кэрролл
Хуберт Лэм
Лиза К. Макнил
Венди Джейн Брум
Original Assignee
Геноцеа Байосайенсиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Геноцеа Байосайенсиз, Инк. filed Critical Геноцеа Байосайенсиз, Инк.
Priority claimed from PCT/US2019/053672 external-priority patent/WO2020069454A1/en
Publication of EA202190856A1 publication Critical patent/EA202190856A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

В данном документе предложены способы и композиции для идентификации опухолевых антигенов лимфоцитов человека и для лечения субъектов, имеющих рак.Provided herein are methods and compositions for identifying tumor antigens of human lymphocytes and for treating subjects with cancer.

EA202190856A 2018-11-09 2019-09-27 METHODS OF TREATMENT EA202190856A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862757915P 2018-11-09 2018-11-09
PCT/US2019/053672 WO2020069454A1 (en) 2018-09-27 2019-09-27 Treatment methods

Publications (1)

Publication Number Publication Date
EA202190856A1 true EA202190856A1 (en) 2021-07-14

Family

ID=77443274

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190856A EA202190856A1 (en) 2018-11-09 2019-09-27 METHODS OF TREATMENT

Country Status (1)

Country Link
EA (1) EA202190856A1 (en)

Similar Documents

Publication Publication Date Title
MX2019011148A (en) Treatment methods.
CY1122642T1 (en) ANTI-B7-H1 AND ANTI-CTLA-4 ANTIBODIES FOR THE THERAPEUTIC TREATMENT OF NON-SMALL CELL LUNG CANCER
CL2020003071A1 (en) Multispecific binding proteins and enhancements with them
EA201792191A1 (en) FGFR / PD-1 COMBINED THERAPY FOR THE TREATMENT OF MALIGNANT TUMOR
EA201691866A1 (en) TUMOR LYMPHOCYTES PERMITTING FOR ADAPTIVE CELL THERAPY
EA201790755A1 (en) MODULATION OF STIMULATING AND NONSTIMULATING MYELOID CELLS
EA201790404A1 (en) MACROPINOCYTOZING HUMAN ANTI-CD46 ANTIBODIES AND TARGET TREATMENT OF CANCER
EA201990296A1 (en) ANTIBODIES AGAINST SIGLEC-7 FOR CANCER TREATMENT
EA201691487A1 (en) HUMAN ANTIBODIES TO PD-L1
EA201791736A1 (en) COMBINED THERAPY FOR CANCER TREATMENT
EA202190862A1 (en) METHODS OF TREATMENT
EA202191257A1 (en) ANTI-CANCER THERAPY BASED ON IMMUNOCYTES BINDING LIV1
EA202191769A1 (en) TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
EA202090387A1 (en) PROTEINS BINDING NKG2D, CD16 AND FLT3
EA201891968A1 (en) COMBINED TREATMENT USING LIV1-ADC AND CHEMOTHERAPEUTIC MEANS
EA202192400A1 (en) ANTIBODIES AGAINST INTEGRIN AND THEIR USE
MX2018009499A (en) Egfl6 specific monoclonal antibodies and methods of their use.
CO2021005234A2 (en) Treatment methods
EA202090260A1 (en) MEANS AND METHODS FOR HUMAN AAV GENOTHERAPY
EA201792294A1 (en) COMBINED TREATMENT (OPTIONS) WITH THE USE OF SERIBANTUMAB
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA202191081A1 (en) NEW CANCER ANTIGENS AND ACCOMPANYING METHODS
EA202191058A1 (en) ANTIBODIES AGAINST MUCIN-16 AND METHODS OF THEIR APPLICATION
EA202190226A1 (en) METHODS FOR TREATMENT OF HFpEF USING DAPAGLIFLOSIN AND COMPOSITIONS CONTAINING IT
EA201992852A1 (en) DOSAGE DIAGRAM FOR TESETAXEL AND CAPETSITABINE